share_log

普华和顺(1358.HK)

PricewaterhouseCoopers (1358.HK)

時富證券 ·  Oct 29, 2013 00:00  · Researches

Company introduction

Prudential Heshun is a medical device company in China. The company focuses on the rapid growth of China's medical device industry and the Gaolirun division. It mainly engages in the two business segments of orthopedic implants and infusions. In terms of orthopedic implants, the company sells wound and spine products under the “Walkman” brand and joint products under the “Bourne” brand. In terms of the infuser division, the company supplies two types of high-end infusers through its subsidiary company Volt Technology and its “Volt” brand. The company mainly sells its products through distributors. The company plans to further develop and strengthen the market positions of its two major business segments in the market, and may expand into other attractive segments in the Chinese medical device industry.

For the three years ended December 31, 2012 and the six months ended June 30, 2013, the company's revenue was divided into RMB 60.8 million, RMB 175.3 million, RMB 331.5 million, and RMB 218.8 million. In the same period, the company's net profit was RMB 14.3 million, RMB 493 million, RMB 100.2 million, and RMB 60.2 million.

Assumed use of proceeds

Assuming that the over-allotment rights were not exercised, the net proceeds from the sale of shares were estimated at approximately HK$1,185 million based on the median sale price of HK$2.99 per share.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment